This study aimed to measure supplement consumption behavior and mental health status among Indonesian adults during the second year of COVID-19. Participants and Methods: Online questionnaire regarding supplement consumption, and Depression, Anxiety, Stress Scale 21 (DASS-21) was distributed from March to June 2021 and obtained 1006 valid and completed questionnaires. Descriptive and inferential analyses were conducted to determine the frequency and predictor factors of the respondents' supplement consumption behavior and mental health status. Results: Respondents were divided into two groups, vulnerable and non-vulnerable individuals. The finding showed that 34.5% respondents were vulnerable individuals, including the elderly and those with comorbid disease(s). The vulnerable and non-vulnerable groups exhibited a high prevalence of supplement consumption, with the vulnerable group demonstrating a greater tendency for regular use. The incidence of mental health problems in both groups did not significantly differ (23-38%), where anxiety was higher than depression and stress. Supplement consumption was associated with mental health status. Several positive predicting factors for supplement consumption behavior included older age, higher economic status, and higher education. While the younger age and unmarried respondents were more likely to develop mental health problems. Conclusion: Taken together, given dietary supplement consumption increased during the pandemic and the potential associations between supplement consumption and mental health, controlling the correct information and regulation regarding supplements, especially their risks and benefits, was important. Additionally, support for mental health issues was necessary, since it might affect self-medication behavior.
Background: To increase vaccination coverage, it is important to understand COVID-19 vaccination programs and respondents’ acceptance. Therefore, this study aimed to measure respondents’ knowledge of the COVID-19 vaccine and its acceptance among Indonesian adults in Java. Methods: A web-based survey was distributed through social media on self-claimed knowledge, risk and benefits of the vaccine, as well as respondents’ acceptance and experiences of the vaccination. The survey period was from March to July 2021, and 910 responses were included for further analysis. The frequency of each categorical factor, including self-claimed knowledge of the COVID-19 vaccine, their descriptive benefit and side effects of the COVID-19 vaccine, and their experiences receiving or not receiving the vaccine were explored. Predictor factors on vaccine knowledge and acceptance are investigated using multivariate ordinal regression analysis. Results: This study showed that almost all the respondents in both groups have knowledge about COVID-19 vaccination, or at least ever heard about it. The main source of information is social media. More than two third of respondents from each group had already received a COVID-19 vaccine or were at least on the waiting list. Moreover, a quarter of the respondents still hesitate to receive the vaccination. Only less than 10% of respondents reject the vaccination, with the strongest reason being scared of the side effect. Moreover, it found that respondents’ knowledge of the vaccination was influenced by age, medical background, a history of relatives who tested positive for COVID-19, source of information, economic status, and education levels. Moreover, the acceptance was influenced by age, knowledge about vaccines, and having medical background. Conclusions: This study showed high levels of knowledge and acceptance of the COVID-19 vaccine among adults in Java. Increasing understanding or knowledge about COVID-19 vaccine risks and benefits is necessary to reduce vaccination hesitancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.